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Red blood cells  (RBCs) sensitized with immunoglobulin  G  (IgG) or with the 
third component of complement  (C3)  are bound to the surface of mononuclear 
phagocytes  (1,  2).  This  cell-cell  interaction  results  in  damage  to  the  RBC, 
characterized in vitro by enhanced RBC osmotic fragility and spherocytosis  (1, 
3). A similar process in vivo appears to underlie the spherocytosis characteristic 
of warm antibody (IgG)-induced hemolysis  (1) and found in some patients with 
cold agglutinin  (IgM-C3) disease  (4). 
The  multivalent  plant  lectin  concanavalin  A  (Con A)  binds  to the  surface 
membrane  of many  cells  and may mediate the  association  of like cells  (as in 
RBC  agglutination)  or that  of dissimilar  cells.  More particularly,  Con A  has 
been used to bind monocytes or macrophages  to several target cells,  including 
bacteria (5), murine tumor cells (6), and murine RBCs (7). The present study ex- 
plores the binding by human peripheral blood monocytes of homologous RBCs 
coated with Con A  and the consequent damage inflicted on the bound RBC. 
Materials and Methods 
Mononuclear Cell Monolayers.  Mononuclear  cell  monolayers  were  prepared  from  density 
gradient centrifugation of human peripheral blood as previously described (8). 
Concanavalin A.  Con A  CGrade IV"; Sigma Chemical Co., St. Louis, Mo.) was labeled with 
12~I using the method of McConahey and Dixon  (9).  The labeled protein had identical biologic 
activity to unlabeled Con A  (by hemagglutination titer and monocyte binding, see below),  a- 
Methyl-D-mannopyranoside  (a-MM)  (Sigma  Chemical  Co.)  was  used to inhibit the saccharide- 
binding sites of Con A. 
Sensitization  of RBCs.  Heparinized  whole  blood  was  washed twice  with  0.01  M  EDTA  in 
isotonic veronal-buffered saline (pH 7.4) containing 0.1% gelatin. RBCs (1 ×  l0  s RBC/ml in Hanks' 
balanced salt solution [HBSS]) were sensitized at 37°C for 30 rain with an equal volume of Con A in 
0.15 M NaC1, washed once, and resuspended to 5  ×  107/ml in HBSS. To determine the number of 
molecules of Con A  per cell,  RBCs were sensitized with 125I-radiolabeled Con A,  centrifuged at 
1,000 g, washed,  resuspended in buffer, and their radioactivity determined in a  gamma counter 
(Searle Analytic, Inc., Des Plaines, Ill.). Con A was assumed to be largely tetrameric with a mol 
wt of 112,000 daltons under the conditions of the binding experiments (10).  IgG-sensitized RBCs 
were prepared as previously described (8) using human anti-D antiserum (Sera-Tec Biologicals, 
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New Brunswick, N. J.).  The average number of IgG molecules per RBC was determined by C1 
fixation and transfer (11). 
Monocyte Binding and Phagocytosis of  RBCs.  To examine RBC binding by monocytes, 1 ml of 
HBSS containing 5 ×  107 RBCs was added to tissue culture dishes containing the monolayer. After 
incubation at 37°C,  dishes were washed,  air dried,  and stained with Wright's-Giemsa. Blinded 
replicate  plates  were  examined  by  light  microscopy.  The  number  of  RBCs  attached  to  100 
monocytes was recorded and the data expressed as mean RBCs per monocyte and percentage of 
monocytes binding ->2 RBCs. Phagocytosis of RBCs was examined after hypotonic lysis of extra- 
cellular RBCs and expressed as both the mean number of RBCs within 100 monocytes and the 
mean percentage of monocytes containing any RBCs. 
Determination of  RBC Osmotic Fragility,  51Cr  sodium dichromate (100 ~Ci/ml of whole blood) 
labeled RBCs were sensitized with Con A and allowed to bind to monocytes. Unbound RBCs were 
washed away and 4 ml of phosphate-buffered saline, pH 7.4, of varying tonicity was added to each 
of four replicate plates. After 10 min at room temperature 2.5 ml was removed for determination of 
radioactivity.  To  determine  the  osmotic  fragility  of RBCs  in  suspension,  cells  were  washed, 
resuspended to 1 ×  10  s cells/ml, and 20 ~l were added to 4 ml of osmotic fragility solution. After 
centrifugation,  supernatant  radioactivity  was  counted  and  percent  hemolysis  determined  by 
comparison to the amount of radioactivity at 0.1 grams of sodium chloride/100 ml. 
Results 
Sensitization of  Red Cells.  RBCs (2.5 ×  107/ml) were incubated at 37°C for 30 
min in the presence of 125I-labeled  Con A.  This resulted in  12%  (range  =  7.3- 
15.1%)  of the  labeled  material  becoming  cell  associated.  The  percent  Con  A 
bound remained constant over the range of Con A concentrations from 0.45 to 45 
~g/ml.  A mean 24.4% (range  17.1-28.1%) of the Con A which was bound to the 
RBC  surface  eluted  over  the  course  of 2  h.  Subsequent  vigorous  washing 
removed only 6.7% (range  =  5.4-9.0%) of the remaining  labeled Con A.  Thus, 
the  mean  amount of Con A  bound to RBCs during  their  2-h incubation  with 
monocytes was equivalent to approximately 10% of that present in the medium 
at the time of RBC sensitization. 
Monocyte-Red  Cell Interaction:  The  Rosette.  Incubation  of Con  A-coated 
RBCs with monocytes resulted in binding to form a  rosette (Fig.  1).  Both the 
number of RBCs bound per monocyte and the percent of monocytes that bound 
two or more  RBCs  (Table I) depended  on the  amount  of Con A  on the  RBC 
surface. At a  sensitizing concentration of 10 ~g/ml  (calculated from 125I-Con A 
data to represent approximately 105 molecules of tetrameric Con A per RBC) a 
mean of 2.2 RBCs was bound per monocyte and approximately 50% ofmonocytes 
bound at least two RBCs. 
The  kinetics  of RBC-monocyte binding  in HBSS was investigated  in three 
experiments using sensitizing concentrations of Con A of 42 ~g/ml. RBC binding 
was maximal  at  90  min  and  decreased thereal~r.  By  15  min  nearly  90%  of 
monocytes had bound two or more RBCs, and the percentage subsequently rose 
to 95%. 
Monocytes never bound unsensitized  RBCs. Even after pretreatment  of the 
monocyte monolayer with Con A  in concentrations  ranging  from 6.25 to 1,000 
~g/ml and incubation at various temperatures  (4°C,  22°C,  and 37°C),  unsensi- 
tized RBCs were not bound. 
When Con A-sensitized RBCs were incubated with monocytes in the presence 
of 0.1 M a-MM, rosette formation was totally inhibited. To test the ability of a- 
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Fro.  1.  Con A-sensitized  RBC-monocyte  rosettes.  The  left panel  depicts a  rosette  after  1 h 
incubation.  RBCs  are  distorted  but  not  sphered.  In  the  right  panel  is  a  rosette  after  4  h 
incubation.  Bound  RBCs  are spherocytic.  The unbound  cell (lower right) is morphologically 
normal. 
TABLE  I 
Dose-Response: Concentration of Con A and Binding of RBCs to 
Monocytes 
Sensitizing concentra-  RBCs bound/monocytet  % Monocytes binding* ->2 
tion of Con A*  RBCs 
~/rn/ 
8  0.8 (0.1-1.4)  22 (2--42) 
10  2.2 (2.0-2.5)  50 (49-62) 
16  3.2 (2.4--4.0)  75 (57-90) 
21  4.2 (3.3-5.4)  88 (79-94) 
32  4.8 (4.5-5.0)  88 (87-89) 
42  5,3 (4.9-6.4)  93 (87-97) 
64  6.8 (0.5-7.1)  96 (95-97) 
84  7.0 (5.8-8.1)  97 (94-99) 
* Sensitized RBCs were incubated with monocytes in HBSS for 90 min. 
* Mean and range of four replicate plates for two to five experiments. 
1.5,  and 2.5 h  a-MM was added for 0.5 h. This resulted in the release of 100, 95, 
and 81%, respectively, of bound RBCs. Pretreatment of the monolayer with a- 
MM followed by washing did not alter monocyte binding of Cen A-sensitized 
RBCs. 
Interaction of Monocyte IgG and Con A  "Receptors."  Neither pretreatment 
of monocytes with purified myeloma-derived IgG nor the addition of IgG con- 
comitant  with  the  addition  of Con A-sensitized  RBCs had  any  effect on the 
binding of Con A-sensitized RBCs. In each case binding of IgG anti-D-sensitized 
RBCs was blocked. Pretreatment of the monolayer with Con A at a concentra- 
tion  of 42  ~g/ml  decreased the  binding  of RBCs sensitized  with  Con  A.  In 1698  GUERRY ET AL.  BRIEF DEFINITIVE REPORT 
contrast,  pretreatment of monocyte monolayers with Con A  increased, by a 
mean of 58%, the binding of IgG-sensitized RBCs. The facilitation of binding of 
IgG-coated RBCs was more marked when either the number of IgG molecules 
(200-1,000) bound per RBC or the concentration of Con A to which the monocyte 
was exposed was increased. Facilitation also occurred with RBCs sensitized with 
IgG anti-D isolated by Sephadex G-200 chromatography to be free of detectable 
IgM. The facilitation of IgG-RBC binding by Con A was blocked by the prior 
addition of a-MM  and  reversed  by  addition of a-MM  after  binding of IgG 
sensitized RBCs. 
Osmotic Fragility and Sphering of  Red Cells Bound to Monocytes.  By 4 h of 
incubation 51Cr-labeled RBCs bound to monocytes were significantly osmotically 
fragile compared to those incubated in the absence of monocytes (Fig. 2). RBCs 
removed from the  monocyte with  a-MM  after  4  h  of incubation were  also 
osmotically fragile as compared to cells that had not become monocyte adherent. 
By light microscopy, RBC attached to monocytes for 1 h appeared distorted, but 
often maintained an area of central pallor, whereas RBCs attached for 4 h were 
spherocytic (Fig. 1). 
Phagocytosis of Con A-Sensitized RBC.  In three of three experiments, the 
percentage of monocytes ingesting RBCs never exceeded 6.5% and the mean was 
4% at 1 h and 2% at 4 h. The total number of RBCs interiorized was also small, 
with a  mean of 4.5  RBCs per  100  monocytes at  1 h  and 2.0  RBCs per  100 
monocytes at 4 h. 
Discussion 
The recognition (binding) of a  variety of objects, from latex spheres to nu- 
cleated cells, is a fundamental property of the phagocyte. Binding may be of no 
apparent consequence, as in macrophage interaction with mycoplasma orga- 
nisms (12) or RBCs sensitized with only F(ab')2 immunoglobulin  fragments (13). 
Under the appropriate circumstances, however, binding is the prelude to inges- 
tion of the object and its subsequent attack by digestive enzymes. Intermediate 
between the poles of inconsequential binding and "phagocytic recognition" may 
be those phenomena in which binding leads to an alteration of the bound object 
without it being ingested. The sphering of RBCs bound to monocytes with Con 
A, as in the present study, or with IgG anti-D (1) or C3 (3) is one manifestation of 
this  process.  Con  A-mediated sphering  may be  the  counterpart  of the  old 
observation of Ham and Castle that injection of Con A into dogs produces in vivo 
spherocytosis and hemolysis (14). 
Several  lines  of evidence  implicate  Con  A  as  directly  linking RBC  and 
monocyte. First,  unsensitized RBCs were  not bound.  Second, the  degree of 
binding of sensitized RBCs was dependent on the number of molecules of Con A 
placed on the RBC surface. Third, binding was both prevented and reversed by 
~-MM,  Con A's specific saccharide  inhibitor.  Finally,  Con A  placed on the 
monocyte inhibited the subsequent attachment of Con A-coated RBCs. 
While  Con  A-mediated binding and  sphering of RBCs  parallels  immune 
recognition and damage, it does not appear to involve the IgG receptor. Never- 
theless, a functional interaction between the IgG and Con A receptors could be 
demonstrated, since binding of IgG-sensitized RBCs was increased by pretreat- 
ing monocytes with Con A.  Possibly once a  recognition point is  established GUERRY  ET AL.  BRIEF  DEFINITIVE  REPORT  1699 
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Fro.  2.  Osmotic fragility  curves of RBCs  bound to  monocytes for  4  h  (open  circles)  or 
incubated without monocytes for 4 h  (closed circles).  The arrows designate the concentra- 
tion of sodium chloride at which 50% of 51Cr-labeled Con A-sensitized RBCs were lysed. The 
data represent means  -  SEM for quadruplicate plates in six of six experiments. 
physical association of RBC and phagocyte occurs and binding becomes estab- 
lished if other molecules of either IgG or Con A engage their complementary 
monocyte  receptors. Enhanced binding did not occur because of Con A binding to 
saccharide residues on contaminating IgM as the same phenomenon was seen 
with column purified IgG. It is possible that the small amount of carbohydrate 
associated  with  IgG  anti-D  (15) is  the  site  of attachment of Con  A.  That 
enhanced binding is probably not mediated by a change in the state of "activa- 
tion" (16) of the mononuclear phagocyte is indicated by the reversal of enhance- 
ment by ~-MM. 
The precise nature of the events involved in the transition from recognition to 
phagocytosis are as yet only incompletely  understood. In our system, phagocyto- 
sis of Con A-sensitized RBCs was minimal, as it is under certain circumstances 
with IgG coating the RBC (1) and under many circumstances in which C3 is the 
only substance sensitizing the RBC (2, 17, 18). Despite minimal interiorization 
of Con A-coated RBCs, spherocytes were produced at the phagocytic cell surface. 
That sphering can occur without bulk phagocytosis and that phagocytosis can 
proceed without producing spherocytes (7) suggests important functional differ- 
ences in the two phenomena. While rosetting may be "a truncated version of 
ingestion" (19), it provides a  means by which surface-bound particles can be 
altered-the RBC sphered, the antigen processed, and the lymphocyte commu- 
nicated with-without being engulfed and destroyed. 
Summary 
Human red  blood  cells  sensitized  with  concanavalin A  became bound  to 
homologous peripheral blood monocytes. Binding occurred at a concentration of 
105 molecules of tetrameric Con A per red blood cell (RBC) and increased with 
additional Con A. RBC binding began within 5 min and was maximal at 90 min. 
Phagocytosis of sensitized RBCs was minimal. RBC attachment was prevented 
by 0.01 M a-methyl-D-mannopyranoside, and, once the RBC-monocyte rosette 
was established, bound RBCs were largely removed with this specific saccharide 
inhibitor of Con A. RBCs attached to monocytes  became spherocytic and osmoti- 
cally fragile. The recognition of concanavalin A  (Con A)-coated RBCs was not 
mediated through the monocyte IgG-Fc receptor. These studies demonstrate 1700  GUERRY ET  AL.  BRIEF DEFINITIVE  REPORT 
that,  like IgG and C3b,  Con A  is capable of mediating the binding of human 
RBCs to human monocytes. Red cells so bound are damaged at the monocyte 
surface. 
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